Article Details

Recro Pharma (NASDAQ:REPH) Stock Rating Lowered by Zacks Investment Research

Retrieved on: 2021-02-12 08:28:35

Tags for this article:

Click the tags to see associated articles and topics

Recro Pharma (NASDAQ:REPH) Stock Rating Lowered by Zacks Investment Research. View article details on hiswai:

Excerpt

WINTON GROUP Ltd purchased a new stake in Recro Pharma in the 3rd quarter valued at $63,000. Strs Ohio lifted its stake in Recro Pharma by 140.8% ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up